Endoscopic Ultrasound Needles Market Expected to Raise Total Valuation of US$ 223.5 Mn by the End of 2027

According to the latest study by Future Market Insights (FMI),  global endoscopic ultrasound needles market size is projected to increase from a valuation of US$ 180.2 Mn in 2022 to US$ 223.5 Mn by the end of 2027

The endoscopic ultrasound needles market is witnessing the advent of wide range of products including technological advancements in FNA and FNB for solid lesions. Endoscopic ultrasound have gained wide acceptance among surgeons as minimally invasive procedure along with EUS guided needles as the safe and minimally invasive method driving endoscopic ultrasound needles market growth.

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-9247

Manufacturers in the endoscopic ultrasound needles market are focusing on new product launches for more precise diagnosis of tissues collected using needles. Gaining a greater share in the endoscopic ultrasound needles market with diverse portfolio is one of the key strategies of leading players.

As per the report, companies in the endoscopic ultrasound needles market are also focusing on collaborating for development and distribution of advanced endoscopic ultrasound needle products.

Key players in endoscopic ultrasound needles market are focusing on new product development in emerging regions including Latin America and Asia Pacific owing to the increasing prevalence of cancer and other chronic diseases.

Endoscopic Ultrasound-Guided Fine Needle Aspiration to Gain Popularity with Rise in Gastrointestinal Diseases

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-9247

According to the FMI report, Endoscopic Ultrasound-Guided Fine Needle Aspiration (EUS-FNA) is likely to account for largest share in the endoscopic ultrasound needles market. EUS-FNA gaining popularity for the diagnosis of gastrointestinal diseases and peri-gastrointestinal lesions. The wide application of FNA has also accelerated the growth in the endoscopic ultrasound needles market.

With the growing demand for minimally invasive procedures, doctors and surgeons are using EUS combined with FNA to collect sample fluid and tissue from chest and abdomen for diagnosis. It has also emerged as an alternative to exploratory procedure.

Meanwhile, in recent years studies conducted on Endoscopic Ultrasound-Guided Fine Needle Biopsy (EUS-FNB) have shown some promising results. As per the FMI study on endoscopic ultrasound needles market, FNB is emerging as the novel tool in diagnosis by providing information on tissue architecture.

As per the study, ambulatory surgical centres will use endoscopic ultrasound needles on a large scale owing to the rise in number of these centres and increasing number of endoscopic ultrasound surgeries performed in ambulatory surgical centres.

Being the minimally invasive and non-surgical procedure that can be performed through colon or upper GI tract, ambulatory surgical centers are gaining traction in the endoscopic ultrasound needles market.

Moreover, endoscopic ultrasound is generally considered safe when performed at ambulatory surgical centres with expert healthcare team. Various healthcare organisations are building ambulatory surgical centres within the premises in the healthcare facility offering wide range of services with technological advancements to achieve economies of scale.

Increasing number of ambulatory surgical centers are offering safe, cost-effective services, especially for gastroenterology, thereby, driving the demand in the endoscopic ultrasound needles market.

Contact Sales for Further Assistance in Purchasing this Report https://www.futuremarketinsights.com/checkout/9247

Endoscopic Ultrasound Needles Industry Survey

Endoscopic Ultrasound Needles Market by Product:

  • Aspiration Needles (EUS-FNA)
  • Biopsy Needles (EUS-FNB)

Endoscopic Ultrasound Needles Market by Application:

  • Bronchial EUS Needles
  • Enteral EUS Needles

Endoscopic Ultrasound Needles Market by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Endoscopic Ultrasound Needles Market by Region:

  • North America Endoscopic Ultrasound Needles Market
  • Latin America Endoscopic Ultrasound Needles Market
  • Europe Endoscopic Ultrasound Needles Market
  • East Asia Endoscopic Ultrasound Needles Market
  • South Asia & Pacific Endoscopic Ultrasound Needles Market
  • Middle East & Africa (MEA) Endoscopic Ultrasound Needles Market

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Loop-mediated Isothermal Amplification (LAMP) Market is expected to reach US$ 120.4 Milion by 2028

Global demand for loop-mediated isothermal amplification technology reached around US$ 85 million in 2018, as indicated by a new research study of Future Market Insights (FMI). Estimated to observe stable growth in revenue over the coming years, loop-mediated isothermal amplification market will witness dominance of DNA polymerase, among the various product types.

Dominance of DNA Polymerase Adoption to Prevail, LAMP Instruments to Emerge Lucrative

DNA polymerase will continue to find highest applicability in both research and diagnostics. According to FMI’s report, DNA polymerase will be the key revenue generating product in loop-mediated isothermal amplification market over the period of projection. However, the report also highlights that instruments such as turbidimeters and fluorescence measuring systems will prominent traction in loop-mediated isothermal amplification market through 2028.

Amongst various loop-mediated isothermal amplification technologies, micro-fluidic technology majorly, have been successfully used in the diagnosis of several diseases including malaria and tuberculosis. Loop-mediated isothermal amplification using DNA polymerase has seen a rapid rise in the past several years due to the high adoption of loop-mediated isothermal amplification in testing.

The application of these Loop-mediated isothermal amplification in assessing and directing diagnosis in certain types of disease, such as acute malaria, has provided a new dimension to the gradually growing field of minimal residual disease management.

To remain ‘ahead’ of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-5532

High Penetration of Cutting-edge Technology Molecular Diagnostics of Fatal Diseases to Push LAMP Market Growth

The simplicity sensibility and specificity of loop-mediated isothermal amplification puts it in a very good position for future development in life threatening disease diagnosis. It is anticipated that the loop-mediated isothermal amplification market will grow significantly during the forecast period, owing mainly due to demand for advanced molecular diagnostics to accurately diagnose life-threatening diseases.

In recent years, the detection and identification of nucleic acids using point-of-care total nucleic acid analysis systems and procedures are in rise including loop-mediated isothermal amplification in various clinical and industrial settings. Besides loop-mediated isothermal amplification has also challenged PCR based amplification as it could achieve enhanced nucleic acid amplification by increasing surface area to volume ratio with reduced testing cost.

Macroeconomic indicators such as government funding for advancement and increased research on disease epigenetics; establishment of network of distribution and marketing agreements to ensure availability of products to different loop-mediated isothermal amplification end users globally; liberalization of import and export trade on point of care diagnostic devices and chemical reagents are also anticipated to propel the growth of the loop-mediated isothermal amplification market.

Key Challenges Facing Development of Loop-mediated Isothermal Amplification Market

On the grey side, loop-mediated isothermal amplification has several intrinsic disadvantages such as its amplification method is devoid of an internal PCR inhibition control (IC). It is essential to perform all the reactions in duplicate, one being or the target and the other one for the IC in loop-mediated isothermal amplification assay.

Moreover, most standard DNA polymerases are unable to exhibit activity in samples derived from crude lysate due to the presence of polymerase inhibitors. This adds complexity to the loop-mediated isothermal amplification processing due to additional steps involved in purifying DNA to be used for amplification, which could also result in loss of starting material.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-5532

Loop-Mediated Isothermal Amplification Market: Additional Questions Answered

  • What is the revenue potential of the Loop-Mediated Isothermal Amplification Markets across North America and Europe?
  • Who are the key competitors and what are their portfolios in the Loop-Mediated Isothermal Amplification Market?
  • What are the major challenges influencing the growth of the Loop-Mediated Isothermal Amplification Market?
  • How is intervention from regulatory authorities shaping the growth of the Loop-Mediated Isothermal Amplification Market?

Regions with High Disease Prevalence to Reflect High Growth Potential for LAMP Market

Due to increase in prevalence of malaria and other pandemic diseases, regions such as East and South Asia are anticipated to be the fastest growing regional loop-mediated isothermal amplification markets and are poised to offer tremendous opportunities to key players. The increase in disease prevalence will increase the demand for the use of loop-mediated isothermal amplification for point-of-care diagnosis. Besides, distribution & collaboration agreements by leading players of loop-mediated isothermal amplification products with the established local distributors in the regions will fuel the market growth of both the regions.

The loop-mediated isothermal amplification market report tracks some of the key companies operating in the global loop-mediated isothermal amplification market such as :

  • Eiken Chemcial Co.Ltd
  • New England Biolabs
  • Jena Bioscience GmbH
  • NIPPON GENE CO.
  • LTD
  • HUMAN
  • Optigene
  • HiberGene Diagnostics
  • Meridian Bioscience Inc.
  •  Mast Group Ltd.

Key Segment

Based on product type

  • instruments
    • incubation systemsTurbidimeters
    • Agarose gel electrophoresis
    • fluorescence measuring systems
  • kits & reagents
    • DNA polymerase
    • Primer Mix
    • DNA Polymerase &Primer mix
    • dyes
    • other reagents

Based on Technology

  • microfluidic technology
  • advanced infrared optical technology
  • modern microsystem technology

Based on Application

  • diagnostic
  • research purpose

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-5532

Based on End User

  • hospital & laboratories
  • research & academic institutes
  • others

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Twist Wrap Packaging Market Is Expected to reach USD 584.77 billion by 2022 – 2032

Twist wrap packaging is used for packaging of confectionaries such as toffees, chocolate bars, etc. Twist wrap packaging is used so that there is no need for using adhesive for wrapping the packaging. Another advantage of twist wrap packaging is the high tensile strength and excellent stiffness characteristic. In addition to, twist wrap packaging also possesses excellent barrier against heat and moisture. Twist wrap packaging is also eco-friendly which are enhancing the importance of this type of packaging for confectionaries.
Get Sample of the report @  https://www.futuremarketinsights.com/reports/sample/rep-gb-4922

Twist wrap packaging market participants enter into a licensing agreement with other technologies to use Earth Coating in a wide range of sophisticated packaging applications. The partnership, which would be focused on New Zealand and Australia, extends Earth Coating mineralization of plastics technology into a broad spectrum of flexible packaging applications that necessitate exceptional barrier and heat seal performance.

At the exhibition, key twist wrap packaging market participants will bring to light their expanded product portfolio with the comprehensive acquisition by key players in the twist wrap packaging market to broaden their growth and geographical market coverage options.

Sales have been expanded into EMEA and the Americas. The company has acquired stock. As a result, the company, which provides high-performance new products in Asia, has increased its twist wrap packaging market share.

In Europe, the twist wrap packaging market company has recently announced the opening of its Technical Solutions Center. The one-stop shop meets the technical support needs of its expanding European customer base and reaffirms the company’s continued commitment to the European twist wrap packaging market.

Global Twist Wrap Packaging – Market Dynamics:

The market for twist wrap packaging is increasing due to increase in the preference for this type of packaging by consumers. Another factor which is augmenting twist wrap packaging market is excellent twist retention quality of the wrap. Twist wraps made from aluminium and wax paper are getting a scope for increasing sales for the twist wrap packaging market. Furthermore, the demand for twist wrap packaging market is increasing due to its waterproof ability. In addition, twist wrap packaging also has features such as heat protection capability of the packaging which would keep food items safe. Twist wrap packaging is getting preference as it increases the appearance and aesthetic quality of food items. Moreover, due to strict norms of the government regarding plastic use is hampering the market for twist wrap packaging.

Ask an Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-4922

Global Twist Wrap Packaging Market – Regional Overview:

North America is expected to dominate the market for twist wrap packaging market over the forecast period 2017-2025. It is followed by Europe, which is expected to be the second dominant market for twist wrap packaging. Asia Pacific region is anticipated to witness the highest CAGR during the forecast period for global twist wrap packaging market due to increasing preference for confectionaries in the young generation. Latin America and Middle East & Africa are expected to witness above average growth over the forecast period for the twist wrap packaging market.

Global Twist Wrap Packaging Market – Key players:

Few of the key players in the twist wrap packaging market are Exxon Mobil Corp, Clondalkin Group Holdings B.V., TOPAS Advanced Polymers GmbH, Catty Corporation, Elif Plastik Ambalaj San. ve Tic. A.?., Stratex Group Limited, Swiss Pack U.K., Foil Packaging Pvt Ltd, Multifilm Packaging Corporation, Ester Industries Ltd., BPM Inc., Varipack AG, Polysack Flexible Packaging Ltd., etc.

The report covers exhaustive analysis on:

  • Global Twist Wrap Packaging Market Segments
  • Global Twist Wrap Packaging Market Dynamics
  • Historical Actual Market Size, 2012 – 2016
  • Global Twist Wrap Packaging Market Size & Forecast 2017 to 2027
  • Supply & Demand Value Chain for Twist Wrap Packaging Market
  • Global Twist Wrap Packaging Market Current Trends/Issues/Challenges
  • Competition & Companies involved in Twist Wrap Packaging Market
  • High Altitude Aeronautical Platform Stations Technology
  • Value Chain of High Altitude Aeronautical Platform Stations
  • Global Twist Wrap Packaging Market Drivers and Restraints
  •  The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-4922

Global Twist Wrap Packaging – Market Segmentation:

The global twist wrap packaging market can be segmented by the raw material type, by product type, and by end user base.

On the basis of raw material type, the global twist wrap packaging market is segmented into

  • Plastic
  • Polypropylene (PP)
  • Polyethylene (PE)
  • Polyvinyl Chloride (PVC)
  • Cellophane
  • Others
  • Wax Paper
  • Aluminium
  • Others

On the basis of application, the global twist wrap packaging market is segmented into –

  • Gift Wraps
  • Confectionary Packaging
  • Candy
  • Chocolate bars
  • Jelly
  • Others

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.

About Us:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

Website: https://www.futuremarketinsights.com

LinkedIn| Twitter| Blogs

Auto-Injectors Market is projected to enjoy a valuation of US$ 3.5 Billion in 2022 | FMI

Anaphylactic shock is the most common chronic disease in Europe and North America region. Allergy UK says, approximately 20% of patients struggle with anaphylactic reaction in Europe. Anaphylactic shock requires adrenaline auto injector devices to be treated. Adrenaline auto injectors are sold under various brands, such as Emerade, Epipen and Jext in the UK. The global auto injectors market was valued at US$ US$ 1,700 Mn, in terms of value, in 2016, according to the latest research by Future Market Insights (FMI). The report on auto injectors further projects significant growth potential with average year-on-year growth rate of 15.1% through 2026.

Auto injectors are an effective mode of administration for intramuscular drugs. User friendly attributes of auto injectors reduce the burden of carrying conventional needles and syringes. However, limited awareness regarding proper use of auto injectors and high price of branded products are some of the important factors curbing the adoption of auto injector devices in emergency applications.

Get a Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1642

Based on research conducted by the McGill University’s Health Centre Research Institute, allergic patients procuring EpiPen for emergency are not actually using the product as quickly as they should. Further, a number of patients visiting the emergency department due to severe anaphylaxis reaction are already administered epinephrine, says the Journal of Allergy and Clinical Immunology.

Failure to use auto injectors at the right time is mainly due to lack of knowledge about signs of anaphylaxis. Such lack of awareness about the disease and product creates significant challenges, in terms of product adoption, for the manufacturers. Apart from higher pricing, limited shelf life of auto-injector pen & under supply of products (Ex. EpiPen) are the major challenges hindering the patient preference for auto injectors in emergency.

Increasing innovations in materials and device functions of auto-injectors are driving the expansion of the auto injector market. In September 2015, Bayer HealthCare reported the launch of Betaconnect- an electronic auto injector for the treatment of relapsing-remitting multiple sclerosis (RRMS). This auto injector offers complete drug dosage for improved compliance and potentially reduce the overall cost. The SHL Group offers a variety of auto injectors that can accommodate changes in injections, such as larger volumes, high viscosity and others. The auto-injector manufacturers are focusing on improving the functionality of auto-injectors to improve disease management and treatment.

Fierce competition in the auto injectors market due to the patient protection act has created an oligopolistic market environment. As a result, brands, such as EpiPen auto-injector, BD Physioject disposable auto injector, etc., have maintained their ranks in the market. However, recent patient expiration and increasing pressure from government bodies will led to reduction in auto injector prices and thus, reduce the profitability for branded manufacturers.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-1642

Generic auto injectors are expected to present high growth opportunities for investors due to growing support from private insurance providers. Insurance services providers are dropping coverage on highly priced auto injectors and covering newly launched half priced generics. Overall revenue from pre-filled syringes is expected to grow during the forecast period due to rising need for targeted and sustained drug delivery. New entrants must comprehensively study the Auto Injectors market to penetrate and sustain in the price sensitive market. The study of the market scenario will provide insights about the business opportunities

FMI has segmented the global auto injector market by product type, indication, distribution channel & regions. In terms of revenues, pre-filled auto injectors will hold substantial market share over the forecast period. On the contrary, the Fillable auto-injectors segment will exhibit limited investment opportunities, in terms of revenue, through 2026.

This FMI report covers some of the key companies operating in the auto injectors market, such as

  • Sanofi, Pfizer, Inc.,
  • Becton,
  • Dickinson and Company,
  • Mylan N.V.,
  • Novartis AG,
  • Janssen Global Services,
  • LLC,
  • Antares Pharma,
  • Amgen Inc.
  • Bayer AG, & Eli Lilly and Company.

Buy Complete Report@ https://www.futuremarketinsights.com/checkout/1642

Key Segment

based on product type

  • Prefilled Auto-injectors
  • Fillable auto-injectors

based on distribution channel

  • Traditional sales channels
  • hospital pharmacies
  • retail pharmacies

based on regions

  • North America
  • Latin America
  • Europe
  • Asia Pacific Excluding Japan
  • Japan
  • MEA

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Middle East Veterinary Vaccines Market is expected to reach US$ 533.4 Million by 2031

[192 Pages Report] According to a recent study by Future Market Insights (FMI), the Middle East Veterinary Vaccines Market is expected to witness moderate growth during the forecast period. The market is expected to grow from US$ 335.0 Mn in 2021 to over US$ 533.4 Mn by 2031. This reflects a cumulative CAGR of around 4.8% over the forecast period (2021-2031).

The demand for veterinary vaccines has increased over the past few years due to the increasing incidences of foodborne and zoonotic infections amongst the population in the Middle Eastern region. The pattern of veterinary treatment is shifting from curative/reactive to preventive in these countries. The cost of preventive treatment is much smaller and has far fewer side effects than reactive treatments that often lead to mass slaughter.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-MA-3086

The rebound of economic prosperity in MEA markets is expected to contribute towards increased demand for processed healthy meat products. This will fuel the demand for effective vaccination of livestock, especially in major animal farming and meat-producing nations in the region with a diversified herd such as Sudan, Turkey, Egypt and KSA.

Rising per capita disposable income levels are largely contributing towards demand for processed food items. This is expected to drive the growth of veterinary vaccines in poultry and livestock segments.

The key players of the veterinary vaccines industry are focusing on finding innovative products to control zoonotic infection rates. Along with this, various advancements in biotechnology are expected to create a favourable platform for the development of various veterinary vaccines in developing markets such as UAE, KSA, Turkey and Jordan. These techniques include next-generation sequencing, synthetic biology and systems biology, among others.

Further, continued investments in multi-disciplinary vaccinology research could improve vaccine development efficiency and shorten time-to-market for upcoming veterinary vaccines.

Key players are working on innovative products, conducting acquisitions, mergers, agreements with other companies to improve their market presence and tap into less competitive emerging markets.

For instance, In September 2018, Boehringer Ingelheim announced that they would be donating 75,000 doses of rabies vaccines to the Global Alliance for the Rabies Control, as an effort of recognition of World Rabies Day on September 28th.

Such developments not only strengthen the company’s existing portfolio but also help to increase their presence at the regional as well as global level, and help companies to sustain the increasing competitive pressure.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-3086

Key Takeaways from Middle East Veterinary Vaccines Study

  • The attenuated live vaccines accounted for 35.1% share of the total market of veterinary vaccines in the Middle East in 2021. The demand for attenuated live vaccines is expected to grow at a CAGR of 5.8% over the forecast period. By triggering a wide spectrum of immune responses, attenuated vaccines can deliver better immunity than conventional vaccinations.
  • The livestock animals held the maximum share of 73.9% of the total veterinary vaccines market in terms of animal in 2021. Increased demand for processed meat products and making animal health a critical component of disease control is leading to increasing adoption of livestock animal’s vaccination in the Middle Eastern region.
  • The foot and mouth disease accounted for more than 27% of the market share of the Middle East veterinary vaccines market in 2021. Foot and mouth disease is the most commonly occurring disease amongst all the animals. This segment is expected to project a cumulative CAGR of 5.6% over the forecast period.
  • The private veterinary pharmacies registered sales worth U.S. $ 114.6 Mn during the year 2021 and are expected to project a cumulative CAGR of 5.0% over the forecast period. Increased awareness regarding animal vaccinations, rising incidences of foot and mouth disease and high demand for good quality processed meat are some of the factors contributing to the growth of private veterinary pharmacies in the Middle East.

“Increased demand for processed meat products around the world will drive the demand for veterinary vaccines market in the Middle East,” says the FMI Analyst.

Who is winning?

The key manufacturers of the veterinary vaccines market are adopting strategies such as partnership strategies for global expansion and improving their hold over the global market.

  • In January 2021, Merck Animal Health announced the acquisition of Poultry Sense Ltd, which provides health and environmental monitoring solutions for the poultry industry.
  • In September 2019, Ceva, in partnership with Biotecon diagnostics, announced the launch of their latest product, a real-time diagnostic kit that will help the poultry producers to fight salmonella infections in their farms.

The key market players of the Middle East veterinary vaccines market include JOVA, Bioveta, Inc., Intervac Pvt. Ltd., Zoetis, Elanco, Merial, Merck & Co. Inc, Bayer Pharma AG, Ceva and Boehringer Ingelheim.

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The Middle East veterinary vaccines market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The study provides compelling insights into the Middle East veterinary vaccines market. The veterinary vaccines market is segmented into five parts based on vaccine type (attenuated live vaccines, inactivated vaccines, toxoid vaccines, DNA vaccines, recombinant vaccines, and others) based on animal type (companion animals, livestock animals and equine) based on disease indication (foot and mouth disease, NewCastle disease, PPRS, canine parvovirus, brucellosis, avian influenza, and others), based on end-user (hospital pharmacies, veterinary clinics, private veterinary pharmacies and others) and based on country ( KSA, UAE, Turkey, Jordan, Sudan, Egypt and Rest of MEA).

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-3086

Middle East Veterinary Vaccines, by Category

By Vaccine:

  • Attenuated Live Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines
  • DNA Vaccines
  • Recombinant Vaccines
  • Others

By Animal:

  • Companion Animals
    • Canine
    • Avian
    • Feline
  • Livestock Animals
    • Aquatic
    • Bovine
    • Porcine
    • Small Ruminant
    • Poultry
  • Equine

By Disease Indication:

  • Foot and Mouth Disease
  • Newcastle Disease
  • PPRS
  • Canine Parvovirus
  • Brucellosis
  • Avian Influenza
  • Others

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Endovenous Laser Therapy Market is projected to reach US$ 811.0 Million by 2031

[151 Pages Report] According to a recent study by Future Market Insights (FMI), the global endovenous laser therapy market is expected to witness high growth during the forecast period. The market is expected to grow from US$ 378.3 Mn in 2021 to over US$ 811.1 Mn by 2031. This reflects a cumulative CAGR of around 7.9% over the forecast period (2022-2031).

Rise in number of varicose veins cases, availability of technologically advanced laser therapy, shift towards minimally invasive procedures and increasing product launches are the primary factors responsible for the growth of the market during the forecast period.

Varicose veins are more common in pregnant women, partially because the baby puts more pressure on the veins and partly because hormones generated during pregnancy relax vein walls. Varicose veins can develop as a result of damage to a deep leg vein. Over the projected period, rising instances of varicose veins are expected to drive revenue growth in the endovenous laser systems market.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2785

Another factor that is having a positive impact on endovenous laser therapy is the rapid change in lifestyle with no physical activity and labour across the globe, as well as the rise in the elderly population, both of which are anticipated to contribute to the global market’s growth over the forecast period. The market is also expected to develop due to the quick and effective technique as well as the growing demand for endovenous laser therapy.Moreover, growing prevalence of obesity worldwide is driving growth of the endovenous laser therapy market. Obesity leads to problems related to blood circulation which leads to varicose veins.

Medical device manufacturers operating in the endovenous laser therapy market are focusing on providing user friendly devices to the end users to minimize chances of manual errors. In addition, continuous launch of new and improved products and increasing investment in research and development by the manufacturers in endovenous laser therapy devices would lead to growth of global market over the forecast period.

Key Takeaways from Endovenous Laser Therapy Market Study

  • Endovenous laser systems held the maximum share of 92.0% in 2021 by component, expanding at a rapid rate owing to the rising number of varicose veins cases and increase in number of product launches with advanced features.
  • Ambulatory surgical centers showed maximum growth among all end users with a market share of 36.2% in 2021 owing to the rise in demand for outpatient surgeries. In countries such as the U.S., endovenous laser therapy for varicose veins is majorly performed in ambulatory surgical centers rather than hospitals in order avoid long-time waiting in big hospital settings, which is why the segment is developing at a rapid rate
  • North America held the largest share of 42.7% of the global endovenous laser therapy market by region in 2021 indicating the growth due to increase in prevalence of obesity and growing number of FDA approvals in North America.

“Growing prevalence of varicose veins, shift towards minimally invasive procedures, availability of novel laser treatment and increasing number of product launches Is Expected to Drive the Demand for Endovenous Laser Therapy over the Decade,” says the FMI Analyst

 Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-2785

Who is winning?

The key market players covered by FMI include AngioDynamics, Inc., Syneron Medical Ltd., Dornier MedTech GmbH, Alma Lasers Ltd., Alna-Medical system GmbH, LSO Medical, Wontech Co., Ltd., intros Medical Laser GmbH and Energist Ltd.

Some of the leading manufacturers of endovenous laser therapy market are focusing on product launch, approvals, collaboration and partnership strategies for global expansion objectives, thereby, enhancing their market presence.

  • In January 2021, Syneron Medical Ltd. announced the availability of the Frax Pro™ system. The FDA-cleared and CE-marked, non-ablative fractional device is the first platform featuring dual-depth skin resurfacing with both Frax 1550™ and the novel Frax 1940™ applicators.
  • In July 2020, Wontech announced that ‘Picowon’, an alexandrite (755nm)-based pico laser, has obtained US Food and Drug Administration (FDA) approval for the first time in Asia and the second in the world.

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global endovenous laser therapy market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The study provides compelling insights on endovenous laser therapy segment based on product (Endovenous Laser Systems {Diode Lasers and YAG Lasers}, and Endovenous laser Fibers {Bare Tip Laser Fiber, Radial Tip Laser Fiber and Gold Tip Laser Fiber}), and end user (hospitals, ambulatory surgical centers and Specialized Clinics) across seven major regions.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-2785

Endovenous laser therapy Market by Category By Product

  • Endovenous Laser Systems
    • Diode Lasers
    • Yag Lasers
  • Endovenous Laser Fibers
    • Bare Tip Laser Fibers
    • Radial Tip Laser Fiber
    • Gold tip Laser Fiber

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Clinics

By Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • Middle East & Africa

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Aromatherapy Market is currently valued at around US$ 5.9 Billion in 2022

[182 Pages Report] The aromatherapy market is estimated to be valued at ~US$ 4.6 Bn in 2019, unveils the new research study by Future Market Insights (FMI). According to the report, the aromatherapy market is projected to grow by ~7% YOY in 2020, primarily influenced by greater emphasis on good health and wellness.

Increasing inclination towards more effective relaxation treatment is giving a boost to the growth of the aromatherapy market. A notable rise in health consciousness and preference for herbal products among consumers, which tend to make intensive use of high-quality and effective products, is further likely to lead to surge in demand for aromatherapy

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-1080

Expansion of Product Lines by Essential Oil Manufacturers

In order to cater to growing demand for essential oils possessing therapeutic properties, various essential oil and diffuser manufacturers are focusing on expanding their product line in the aromatherapy market. For attracting new customers, companies are not only focusing on expanding their distribution network to hypermarkets and supermarkets, but also to premium drugstores and department stores.

Major companies in the aromatherapy market are adopting multi-level or referral marketing strategy to gain distinct competitive edge. Introduction of membership plans are gaining momentum among the aromatherapy market players, where specific members are given significant discount on aromatherapy products. These members are also known as independent salespeople (independent business owners (IBO)) or consultants. Consultants refer essential oils to others and earn some sort of incentives and discounts on their purchase.

Sales via rapidly penetrating e-commerce channels remain a prominent strategy adopted by key players in the recent years. Companies such as Young Living and doTerra, are actively engaging their customers to sign up as distributors to increase the sales of their new products through multi-level marketing plan. In the multi-level marketing strategy, companies are providing membership incentives, rewards, compensation plans, opportunity products, etc. These initiatives taken by the company is thus likely to influence the overall growth of the aromatherapy market.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-1080

Added Benefits of Essential Oils for Various Ailments Aiding the Market Growth

Aromatherapy acts as a complementary treatment in many viral and bacterial diseases such as acute respiratory infections, viral infections, influenza, and bronchitis. Aromatherapy can be used during prophylactic and therapeutic treatment regimens for many diseases such as Initial forms of atherosclerosis, coronary heart disease, neuro-dystonia, hypertension, hypotension, anxiety, depression, insomnia and many such disorders. Thus, added benefits and applications of essential oils in many indications will continue to account for greater gains in the aromatherapy market.

Aromatherapy – A Preferred Therapy to Improve Quality of Life

Studies have been conducted to prove the effectiveness of essential oils that support the body to heal. Essential oils such as thyme, rosemary, oregano, chamomile, and frankincense are used for the treatment of certain benign tumors to selectively harm or disable cancer cells while leaving healthy cells intact. Increasing inclination towards natural remedies provides good growth opportunities for players in the essential oil industry in the near future. Also, presently aromatherapy has been used for cancer patients as it reduces anxiety levels and relieves emotional stress, pain, muscular tension, and fatigue after chemotherapy or post radiation therapy.

Risk Factors Associated with Aromatherapy Restricting Market Growth

Some risk factors and complications are associated with aromatherapy as individuals have unique metabolism, vitality, and physical makeup. Therefore, acceptable dose for one may not be appropriate for others. Risk factors such as toxicity, skin sensitization, photosensitivity etc. have been reported with patients undergoing aromatherapy. However, many essential oils are contraindicated for use during pregnancy and breast-feeding due to their abortifacient properties. Thus, increasing apprehensions regarding the risks of essential oils and other complications result in low preference and reluctance for undergoing aromatherapy by patients, which in turn restrains revenue growth of the aromatherapy market to a certain extent.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-1080

Categorization Of Aromatherapy Industry Survey

Aromatherapy Market by Product:

Aromatherapy Consumables
Essential Oils
Floral
Citrus
Herbaceous
Spicy
Woodsy
Earthy
Camphorous
Others
Blended Oils
Carrier Oils
Aromatherapy Equipment
Nebulizing Diffusers
Ultrasonic Diffusers
Evaporative Diffusers
Heat Diffusers

Aromatherapy Market by Application:

Relaxation
Insomnia
Pain Management
Scar Management
Skin & Hair Care
Cold & Cough
Others

Aromatherapy Market by Mode of Delivery:

Topical Application
Direct Inhalation
Aerial Diffusion

Aromatherapy Market by Distribution Channel:

Aromatherapy Products Sold at Retail Shops
Aromatherapy Products Sold through Online Channels
Direct Distribution of Aromatherapy Products

Aromatherapy Market by Region:

North America Aromatherapy Market
Latin America Aromatherapy Market
Europe Aromatherapy Market
East Asia Aromatherapy Market
South Asia & Pacific Aromatherapy Market
Middle East & Africa (MEA) Aromatherapy Market

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Bone Densitometer Devices Market is likely to grow at a CAGR of 3.5% through 2026

[179 Pages Report] Future Market Insights predicts the US$ 277 Mn global bone densitometer devices market to witness a hike in revenues at a passive CAGR of 3.5% over the next decade. In its recent market outlook titled “Bone Densitometer Devices Market: Global Industry Analysis and Opportunity Assessment, 2016–2026,” the company forecasts that the market for bone densitometer devices will be valued at US$ 390.6 Mn by the end of 2026. Over 2016-2026, bone densitometer devices market is likely to grow passively; however, a few prominent trends will continue to drive market revenues through 2026.

A booming global healthcare market is anticipated to play the role of a key driver in the overall growth of the global bone densitometer devices market. Emerging market trends and several awareness campaigns on osteoporosis rolled out by NGOs across the globe are further likely to increase the demand in the market. Leading companies operating in the global bone densitometer devices market are investing heavily in acquisitions and inking new deals.

These activities are expected to boost the global bone densitometer devices market in the forthcoming years. Leading market players are focusing on new innovations to stay afloat in the global bone densitometer devices market. The rising global trend of medical tourism is likely to benefit key market stakeholders in the next decade.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-733

Key players:

  • Osteosys Co. Ltd,
  • Beammed Ltd.,
  • Diagnostic medical System SA, and
  • Swissray International, Inc

Prevalence of Osteoporosis and Vitamin D deficiency Building Market – Ageing Remains Primary Catalyst

Driven primarily by rising incidences of osteoporosis and other bone-related disorders, the market will also be fuelled by the ensuing awareness about growing osteoporosis incidences. Increased emphasis on preventive healthcare, early diagnosis, and quality treatment are identified to be among the key factors spurring the demand for bone densitometer devices globally. Ageing, resulting in almost threefold risks of acquiring wrist, hip, and vertebral osteoporosis, will remain a major market growth catalyst.

Moreover, increasing prevalence of vitamin D and calcium deficiency disorders will also escalate the demand in near future. Burgeoning cancer prevalence is boosting the number of patients undergoing chemotherapy, which is further identified to affect their bone density in the long run. This will be another driver to growth of bone densitometer market. Evidently increasing integration of DXA into routine health check-ups will also escalate market growth over the forecast period.

Developed Markets Marching Ahead, Asian Countries to Witness Robust Growth

North America will continue to represent the largest market for bone densitometer devices, followed by Western Europe and Asia Pacific. Latin America and MEA will witness relatively lower growth rates.

  • The U.S. will continue to dominate North American market with nearly 75% revenue share of the region and by 2026, North America is expected to surpass a value of US$ 204 Mn, grabbing over half of the market revenue share.
  • APEJ will be the most lucrative, fastest growing market for bone densitometer devices. Led by China, followed by India and ANZ, this region will approach US$ 61 Mn in 2026, expanding at CAGR of 4.2% over 2016-2026. The Chinese market for bone densitometer devices is expected to exceed US$ 20 Mn in revenues, whereas India’s revenues are estimated at over US$ 17 Mn by 2026 end.

Product-wise Segmentation

By product, the global consumption of axial bone densitometer will possibly account for the revenues of US$ 272.3 Mn in 2026. This segment will grow at an estimated 3.7% of CAGR, gaining over 150 BPS during 2016-2026 against peripheral bone densitometer segment. Axial bone densitometer devices will continue to gain higher traction due to superior accuracy and precision, accounting for around 70% value share by 2026. Peripheral bone densitometer segment is also likely to witness steady adoption, as it allows short scan time and lesser exposure to radiation.

Technology-wise Segmentation

Based on technology, dual energy X-ray absorptiometry (DXA) segment is expected to remain dominant with nearly 65% share by 2026 end. This segment will possibly attain a value worth US$ 253 Mn in 2026, expanding at the highest CAGR of 3.7%. Quantitative ultrasound (QUS) segment is anticipated to register a 3.2% of CAGR, reaching over US$ 88 Mn by 2026 end.

End-user-wise Segmentation

In terms of end-user, hospitals segment will remain the largest consumer of bone densitometer devices, accounting for revenues worth US$ 252.3 Mn in 2026. Diagnostic centres, the second largest end-user segment with an estimated value of around US$ 80 Mn by 2026, is expected to witness the highest CAGR of 3.8% over the forecast period. Hospitals are likely to capture around 65% share in 2026, whereas diagnostic centres will bag over 20% share in 2026 market revenues.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-733

Beetling Trends and Upcoming Opportunities Fostering Demand for Bone Densitometer Devices

Increasing adoption of DXA, coupled with growing prominence of ultrasound technology, will be important trends in market. Improving healthcare infrastructure and extended reimbursement for osteoporosis treatment are also highlighted as influential trends. While flourishing medical tourism initiatives will remain a growing trend, strategic M&A activities will continue to trend among key players.

Manufacturers are likely to witness several untapped opportunities in developing Asian markets, which are primarily driven by exploding population and immense healthcare burden. Governments are also increasingly supporting the market through favourable bone density measurement awareness programs.

Global Bone Densitometer Devices Market: Segmentation

By Product

  • Dual Energy X-Ray Absorptiometry (DXA)
  • Peripheral Dual Energy X-Ray
  • Absorptiometry (pDXA)
  • Quantitative Ultrasound (QUS)
  • Others

By Technology

  • Dual Energy X-Ray Absorptiometry (DXA)
  • Peripheral Dual Energy X-Ray
  • Absorptiometry (pDXA)
  • Quantitative Ultrasound (QUS)
  • Others

By End Use

  • Hospitals
  • Orthopedic Clinics
  • Diagnostic Centres

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Radio Frequency Beauty Equipment Market is estimated to be valued at approximately US$ 225 Million by 2026 end

Growing scepticism over invasive cosmetic procedures is diverting consumers towards radio frequency beauty treatments that deliver quick results through non-surgical equipment.

Future Market Insights’ report titled “Radio Frequency Beauty Equipment Market: Global Industry Analysis & Opportunity Assessment, 2016-2026” estimates that the global market for radio frequency beauty equipment, currently valued at US$ 154.6 million, will expand at a robust CAGR of 15.3% and garner US$ 643.9 million in revenues over the forecast period of 2016-2026. The report predicts that the radio frequency beauty equipment market in the Asia Pacific excluding Japan (APEJ) region will expand at the highest CAGR of 20.4%, while Japan will gain revenues worth US$ 40 million by the end of 2026.

Soaring demand for radio frequency beauty equipment is growing on account of higher acceptance of emerging technologies that act as effective alternatives to conventional methods. Global production of radio frequency beauty equipment is anticipated to skyrocket since their demand has been ascending rampantly in both developed and developing markets. In North America, top-grossing industries such as fashion, film and television continue to necessitate the use of complex beauty equipment and devices for enhancing the consumer’s semblance. According to a recent study conducted by Future Market Insights, the radio frequency beauty equipment revenues in North America will account for over 35% revenue share of the market throughout the forecast period.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-1147

Competitive Landscape

Catering to the rising demand for non-invasive beauty treatments, several medical device manufacturers have instated production of radio frequency beauty equipment on a large scale. Rectifying equipment-related complications arising during treatment procedures and reducing the volatile costs of manufacturing remains a top priority for key players in the global radio frequency beauty equipment market.

Cynosure Inc. and Lumenis are among the leading players collectively accounting for three-fourth revenue share of the global market. Strategic acquisitions and product launch are some common business strategies for Syneron Medical Ltd., Alma Lasers, and Valeant Pharmaceutical International, Inc. Other prominent players participating in the growth of the global radio frequency beauty equipment market include Cymedics, IBRAMED, Guangzhou Beautylife Electronic Technology Co. Ltd., and Dermeo.

Surging Demand for Portable Radio Frequency Beauty Equipment

A market share analysis on different types of products – table top devices, trolley mounted devices and portable devices – has estimated that trolley mounted devices will attain the highest value share of the global market for radio frequency beauty equipment through 2026. Nevertheless, trolley mounted radio frequency equipment is anticipated to incur a considerable dip over the forecast period and account for 49% of the market by 2026 end, which will be nearly 6% lesser than the present value share of the segment. While the value share of table top devices in the global market won’t be severely affected throughout the projection tenure, the demand for portable devices, on the other hand, is expected to soar at an impressive pace. By the end of 2026, revenues procured from global sales of portable radio frequency beauty devices are projected to surpass over US$ 135 million, registering increment at fastest CAGR of 19.1%.

Key Research Findings on Global Radio Frequency Beauty Equipment Market 

  • Scars attained from invasive cosmetic surgeries are compelling consumers towards non-invasive procedures performed with radio frequency beauty equipment
  • Skin treatment & body contouring – two prominent applications for radio frequency beauty equipment, will account for nearly 90% value share of the global market by 2026
  • Based on technologies, equipment incorporating a combination of IPL and RF technologies will garner more demand, while the dominant segment of bipolar RF technology will rake in nearly US$ 200 million in revenue by the end of the forecast period
  • Compared to home care settings, beauty care centres will go on to be the largest end-users of radio frequency beauty equipment in 2016 and beyond
  • Serious complications arising from extensive exposure to radio frequency beauty equipment is raising concerns among market participants and end-users.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-1147

Global radio frequency beauty equipment market segmentation

By Product Type

  • Table Top
  • Trolley Mounted
  • Portable

By Technology

  • Mono-Polar Frequency
  • Bio-Polar Radio Frequency
  • Multi-Polar Radio Frequency
  • Fractional Radio Frequency

By Application

  • Skin Treatment
    • Skin Reconstruction
    • Scar Removal
    • Non-Surgical Skin Tightening
    • Facial Repair
  • Body Contouring
    • Liposuction
    • Cellulite Reduction
    • Non-Surgical Fat Reduction
    • Collagen Stimulation and Generation
  • Hair Removal
  • Others

By End User

  • Beauty Care Centre
  • Home Care Settings

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Retinoids Market is expected to reach US$ 2.5 Bn by the end of 2032 | FMI

[250 Pages Report] The global demand for retinoids is expected to rise at a healthy CAGR of 5.4% per year to US$ 1.5 billion in 2022
Retinoids market is anticipated to grow with a significant growth rate over the forecast period 2018-2028. Retinoids are generally prescribed by dermatologists for mild to moderate acne. Retinoids generally come in three different forms: cream, gels, and liquid. These form of retinoids result in reduced keratinization and proliferation of skin cells.
Based on the distribution channel, retinoids market is segmented into retail pharmacies, hospital pharmacies, drug stores, e-commerce, and others. Others distribution channel include supermarkets & hypermarkets and drug stores. Retinoids can be obtained over the counter at supermarkets and pharmacies.Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8060

More than two decades ago, retinoids have been extensively used for the treatment of acne, skin aging, psoriasis, and certain types of cancer. Retinoids are a class of medications which are chemically derived from vitamin A. Retinoids regulate several transcription factors like RXR and RAR located within the nucleus of various cells. Today a variety of retinoids are available in the market: retinol, adapalene, tretinoin, tazarotene, bexarotene, and alitretinoin.

The retinoids come in gel, cream, and liquid forms. Tretinoin is considered the most effective and certainly the most widely investigated retinoid for photo aging therapy.  Tretinoin was the first retinoid approved by the FDA to treat wrinkles. Retinoids slower the growth of skin cells in patients suffering from psoriasis. Retinoids reduce the inflammation and restore the normal epidermal differentiation that is absent in psoriatic lesions. Retinoids are very helpful for many common skin problems but are not without risks like dryness and irritation, changes in skin color, redness, blistering, swelling, and others. Furthermore, retinoids are also used for the treatment of pigmentary disorders like post-inflammatory hyperpigmentation, actinic lentiginous, and melasma.

Retinoids Market: Drivers and Restraints

The increasing burden associated with acne leads patients to seek professional help in the form of prescription treatments. This is further expected to boost the growth of the global retinoids market. Increasing demand for minimally invasive treatment procedure is also driving the growth of the global retinoids market. It is observed that the dermatologists prefer to treat skin problems through less invasive procedures or the use of topical applications compared with surgical methods.

Irritant reactions such as scaling, burning, or dermatitis related with the retinoid therapy may limit their acceptance among the end users which is expected to hamper the growth of the global retinoids market. Furthermore, in order to minimize the side effects caused due to retinoids, people are opting for alternative therapies which are also expected to hamper the growth of the global retinoids market. In order to reduce these side effects, numerous new drug delivery systems have been developed. For instance, nanoparticles have shown a noble potential in improving the tolerability, stability, and efficacy of retinoids like retinol and tretinoin.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-8060

Retinoids Market: Regional Outlook

On the basis of geography, the global retinoids market is segmented into eight key regions, namely North America, Latin America, Western Europe, Eastern Europe, the Asia Pacific excluding China, and Japan, China, Japan, and Middle East & Africa. North America retinoids market is expected to hold maximum market share in the global retinoids market owing to the presence of established market players. Asia Pacific retinoids market is anticipated to grow at a rapid pace with the maximum CAGR over the forecast period due to rising healthcare facilities in the region. However, the retinoids market in low middle-income countries like Latin America, and the Middle East and Africa is anticipated to show a slow growth over the forecast period due to lack of awareness and trained healthcare professionals.

Retinoids Market: Key Players

Some of the key players in the global retinoids market are Mylan N.V., Ion Labs Inc., Bausch Health Companies Inc., GlaxoSmithKline plc, F. Hoffmann-La Roche AG, and others. The established players in the retinoids market are majorly focusing to adopt both organic and inorganic strategies in order to gain more market share in the global retinoids market. Medium sized market players are expanding their geographical presence to increase their market presence in the global retinoids market.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Value Chain

The regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
  • Eastern Europe (Poland, Russia)
  • Asia-Pacific Excluding China and Japan (India, ASEAN, Australia & New Zealand)
  • China
  • Japan
  • The Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-8060
Retinoids Market: Segmentation

The global retinoids market is segmented by retinoids form type, distribution channel and region:

Based on retinoids form type, the global retinoids market is segmented into:

  • Cream
  • Gel
  • Liquid

Based on distribution channel, the global retinoids market is segmented into:

  • Hospital Pharmacies
  • Retail Pharmacies
  • e-commerce
  • Others

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs